Mindfulness in migraine: A narrative review
Expert Review of Neurotherapeutics January 14, 2020 Rebecca Erwin Wells, Elizabeth K. Seng, Robert R Edwards et al. 74 citations
Introduction: Migraine is the second leading cause of disability worldwide, yet many patients are unable to tolerate, benefit from, or afford pharmacological treatment options. Non-pharmacological migraine therapies exist, especially to reduce opioid use, which represents a significant unmet need. Mindfulness-based interventions (MBI) have potential as a non-pharmacological treatment for...